USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Clinical Next-generation Sequencing Market
Global Clinical Next-generation Sequencing Market
Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement
RELEASE DATE
24-Dec-2015
24-Dec-2015
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: 9AB9-00-46-00-00
SKU: LS00160-NA-MR_17130
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
LS00160-NA-MR_17130
Description
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.
Table of Contents
Summary
Market Outlook
Current Regulatory Status of NGS Instruments
Evolution of NGS Testing
NGS for Clinical versus Research Applications
Market Outlook on NGS Clinical Markets—Global
NGS Clinical Landscape—China
NGS Clinical Landscape—United States
Untapped Market for Clinical Applications of NGS—Global
Opportunity Assessment for Clinical NGS
Use of NGS Technology—Global
NGS-based Companion Diagnostics a Near-term Possibility
Points to Consider
Current Protocols for Reimbursement
Success Stories of 3 Companies—What Drives Reimbursement?
Genomic Health
Veracyte
Veracyte (Illumina)
Summary of Reimbursement Coverage Best Practices
Top Bottlenecks
Lessons from Early Adopters
Survey on Clinical NGS
Survey on Clinical NGS (continued)
Key Conclusions and Future Outlook
Analysis from the Genetic Test Repository (GTR)
Test Purpose
Test Method—NGS, Microarray, Sanger, and CGH Based
Tests Offered By Location
Tests Offered By Location (continued)
Selected NGS-based Tests with Clinical Significance
Selected NGS-based Tests with Clinical Significance (continued)
Selected NGS-based Tests with Clinical Significance (continued)
NGS Clinical Test Provider Profiles
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
List for DTC Genetic Testing
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
FDA’s Warning Letters to Manufacturers
List of Approved Companion Diagnostic Kits
List of Approved Companion Diagnostic Kits (continued)
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Popular Topics
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | 9AB9-00-46-00-00 |
| Is Prebook | No |